Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |